Merrimack Pharmaceuticals Inc: DEFA14A filed May 9, 2024

Form type

DEFA14A

Filing date

May 9, 2024

Accession number

0001193125-24-134775

Filer

Merrimack Pharmaceuticals Inc (CIK 1274792)